On March 31, 2025, the Philippines Food and Drug Administration (FDA) released the draft of Guidelines on the Recall of Authorized Health Products Regulated by the Food and Drug Administration. Stakeholders can submit comments to pfpid@fda.gov.ph by May 2, 2025.1